<DOC>
	<DOCNO>NCT00638300</DOCNO>
	<brief_summary>The study 's hypothesis HD large pore dialyzer remove dialysate iron bound potentially dialyzable ligand , 's release intravenous iron compound administer hemodialysis .</brief_summary>
	<brief_title>Removal Ligand-bound Iron During Intravenous ( IV ) Iron Administration Hemodialysis ( HD )</brief_title>
	<detailed_description>Most hemodialysis ( HD ) patient receive HD intravenous iron compound , compose iron core sugar polymer shell . A small percentage iron iron compound release plasma , may associate increase oxidative stress protein oxidation . The study 's hypothesis HD large pore dialyzer may remove dialysate iron bound potentially dialyzable ligand , 's release intravenous iron compound administer hemodialysis . Ligand-bound iron removal also hypothesize affected dialysate calcium bicarbonate concentration , may affect iron-ligand binding . Study Specific aim : To evaluate 1 . Iron removal assess dialysate iron level . 2 . Effect iron removal 's associated experimental condition patient status , assess plasma AOPP level inflammation relate parameter Study include 3 part 1 . Comparing large small pore dialyzer ( To achieve baseline uniform condition , patient uniform dialysate bicarbonate calcium concentration 33 mEq/L 3 mEq/L , respectively , use large pore dialyzer part , besides 2 HD session evaluate low pore dialyzer ) week break Using large pore dialyzer compare 2 . Low high dialysate bicarbonate concentration ( use uniform dialysate calcium concentration 3 mEq/L ) week break 3 . Low high dialysate calcium concentration concentration ( use uniform dialysate bicarbonate 33 mEq/L ) In part , patient first evaluate HD without IV iron administration , serve control evaluation week HD IV iron administration . In part , patient randomize start either one 2 experimental condition , 1 week without evaluation cross-over experimental condition . Patients may participate 1,2 3 part study depend condition .</detailed_description>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Dialysis Solutions</mesh_term>
	<criteria>Chronic hemodialysis patient Acute disease ( infection , thrombosis , ischemia , bleed ) Hepatitis B , Hepatitis C HIV Intravenous iron administration pack red cell transfusion last 3 week prior study Refusal comply limitation fat contain food HD plasma sample AOPP evaluation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>88 Years</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>hemodialysis</keyword>
	<keyword>iron</keyword>
	<keyword>inflammation</keyword>
	<keyword>atomic absorption</keyword>
	<keyword>dialysate</keyword>
	<keyword>advanced oxidation protein product</keyword>
	<keyword>large pore dialysate</keyword>
	<keyword>bicarbonate</keyword>
	<keyword>calcium</keyword>
	<keyword>citrate</keyword>
	<keyword>ligand</keyword>
</DOC>